# Amwell® to report second quarter 2026 operating results
Canonical URL: https://biopharmsignal.com/news/AMWL/amwell-to-report-second-quarter-2026-operating-results-05b3d1ab
Ticker: AMWL
Company: American Well
Source: American Well
Published: 2026-07-24 12:00 EST
## Summary

Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled...

## Article Body
Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2026 operating results after stock market trading hours on Tuesday, August 4.

Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update.

The live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days.

About Amwell Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn .

Investors:

Asher Dewhurst

amwell@icrhealthcare.com

Media:

press@amwell.com
## Recent Company News
- 2026-07-24 12:00 EST — [Amwell® to report second quarter 2026 operating results](https://biopharmsignal.com/news/AMWL/amwell-to-report-second-quarter-2026-operating-results-05b3d1ab) — Source: American Well
- 2026-05-18 11:05 EST — [Nature Human Behaviour study finds SilverCloud® by Amwell® reduced prevalence of mental disorders over two years at scale](https://biopharmsignal.com/news/AMWL/nature-human-behaviour-study-finds-silvercloud-by-amwell-reduced-prevalence-of-m-dd7dd711) — Source: American Well
- 2026-05-11 20:05 EST — [Amwell® to Participate in Upcoming Investor Conference](https://biopharmsignal.com/news/AMWL/amwell-to-participate-in-upcoming-investor-conference-c285d2c6) — Source: American Well
- 2026-05-05 20:05 EST — [Amwell® Announces Results for First Quarter 2026](https://biopharmsignal.com/news/AMWL/amwell-announces-results-for-first-quarter-2026-1abdf658) — Source: American Well
- 2026-04-20 20:05 EST — [Amwell® to report first quarter 2026 operating results](https://biopharmsignal.com/news/AMWL/amwell-to-report-first-quarter-2026-operating-results-ae059d6a) — Source: American Well
## Related News
- 2026-07-28 20:15 EST — BDX — [BD Board Declares Dividend](https://biopharmsignal.com/news/BDX/bd-board-declares-dividend-ea66eb4a)
- 2026-07-28 13:00 EST — ENLV — [Enlivex Announces $400,000,000 Private Placement](https://biopharmsignal.com/news/ENLV/enlivex-announces-400-000-000-private-placement-20e71a7a)
- 2026-07-28 12:30 EST — XRAY — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2)
- 2026-07-28 12:30 EST — RLMD — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11)
- 2026-07-28 12:05 EST — RIGL — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a)